Novavax (NVAX) Is Up 25.9% After Pfizer Matrix-M Deal And Q1 Beat On Expectations
In early May 2026, Novavax reported first-quarter revenue of US$139.51 million versus US$666.66 million a year earlier, swinging…
Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In
In May 2024, Shah Capital, a hedge fund in North Carolina, withdrew from its proxy fight against Novavax’s…
Trump Administration official restricted COVID vaccine approvals, overruling FDA staff
WASHINGTON (AP) — The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted…